Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More
Elravie Premier Light-L
Elravie Premier Light-L is a monophasic dermal filler utilizing advanced HI technology, containing 23mg/ml of highly purified hyaluronic acid with 0.3% lidocaine. Clinically proven to reduce fine wrinkles (crow’s feet, forehead lines) and enhance lip volume for 9-12 months. Award-winning formula (Jang Young-Sil Prize 2014) ensures natural-looking results with minimal downtime and high patient satisfaction rates among cosmetic practitioners.
$25.00
Quantity discounts
| Quantity | Discount | Price |
|---|---|---|
| 5-9 | 4% | $24.00 |
| 10-19 | 8% | $23.00 |
| 20-Unlimited | 10% | $22.50 |
Elravie Premier Light-L Dermal Filler
Elravie Premier Light-L is a monophasic dermal filler utilizing innovative HI technology, awarded the Jang Young-Sil Prize (2014) and Consumer’s Choice Filler Award (2016). With 23mg/ml of highly purified hyaluronic acid and 0.3% lidocaine, it provides natural-looking correction of fine wrinkles with effects lasting 9-12 months. Manufactured by Humedix Co., Ltd. in South Korea under strict quality standards.
Advanced HI Technology
Optimized crosslinking process maximizes HA-BDDE compounds while minimizing residual BDDE for enhanced safety.
Natural Results
Provides subtle volume enhancement and wrinkle correction with natural-looking outcomes.
Long-Lasting Effect
Stable gel structure maintains aesthetic improvements for 9-12 months post-treatment.
Enhanced Comfort
Contains 0.3% lidocaine for improved patient comfort during injection procedures.
Clinical Indications
- Correction of fine perioral wrinkles (“smoker’s lines”)
- Treatment of crow’s feet and forehead wrinkles
- Glabellar lines (between eyebrows) improvement
- Lip augmentation and shape correction
- Décolleté bio-reinforcement for neckline rejuvenation
Key Advantages
Award-Winning Formula
Recognized with prestigious industry awards for innovation and consumer satisfaction.
Superior Safety Profile
Highly purified HA with minimized BDDE residues reduces potential adverse reactions.
Professional Preference
Widely adopted by cosmetic practitioners for its predictable results and ease of use.
Packaging Specifications
Active Ingredients: Hyaluronic Acid 23 mg/ml, Lidocaine 0.3%
Presentation: 1.0 ml pre-filled syringe
Needle: 30G (included)
Manufacturer: Humedix Co., Ltd., South Korea
Storage: Store at room temperature (below 25°C). Do not freeze.
Professional Usage Guidelines
- For intradermal injection only by qualified medical professionals
- Perform aspiration before injection to avoid intravascular administration
- Use proper injection techniques appropriate for the treatment area
- Apply standard aseptic techniques throughout the procedure
- Assess patient’s medical history for contraindications prior to treatment
- Provide appropriate aftercare instructions to patients
Important Safety Information
*Individual results may vary based on factors such as skin type, age, lifestyle, and injection technique.
This product is for professional use only by qualified healthcare practitioners. Not for self-administration.
Contraindications include: hypersensitivity to any components, active skin infections at injection sites, bleeding disorders, or pregnancy/lactation.
We assume no responsibility for adverse effects resulting from improper use or administration by unqualified individuals. Always consult with a licensed medical professional for treatment recommendations.
Related Products
Dermalax Deep Plus
Dermalax Deep Plus is a monophasic hyaluronic acid filler (24mg/ml HA + 0.3% Lidocaine) for correcting moderate-to-deep wrinkles, nasolabial folds, and facial contouring. With 98.7% patient satisfaction in clinical trials, it demonstrates 12-month longevity in 83% of cases. Features ultra-low BDDE residue (<0.5ppm), smooth 27G needle delivery, and dual collagen-stimulating effects for natural volumizing.
Bellast Ultra L
Bellast Ultra L Dermal Filler A next-generation hyaluronic acid gel (20 mg/ml HA + 0.3% Lidocaine) for wrinkle correction (nasolabial folds, perioral lines), lip augmentation, and facial contouring (chin, cheekbones). Features <0.5 EU/ml endotoxins, <2 ppm BDDE residues, and 98.7% biocompatibility (clinical data), delivering natural results lasting 9-12 months with minimal swelling risk (1.2% incidence).
Revolax Fine Lidocaine
Revolax Fine Lidocaine is a premium dermal filler containing 24mg/ml cross-linked hyaluronic acid and 0.3% lidocaine, clinically proven to reduce superficial wrinkles (forehead, crow’s feet, neck) with 89% of users maintaining results for 8-12 months. Ideal for lip augmentation and tear trough correction, its optimized viscosity ensures natural-looking volume while minimizing discomfort.
Chaeum Premium 2
Chaeum Premium is a series of dermal fillers containing highly cross-linked hyaluronic acid (HA). Low temperatures and long duration of the cross-linking reaction used in the production of Chaeum Premium fillers yield even and dense gel structure. Exceptional purity of the product is achieved through prolonged dialysis of the HA after the cross-linking reaction. Minimized residual BDDE and protein levels guarantee the absence of allergic reactions.
Juvederm Ultra 3 (2x1ml)
Juvederm Ultra 3 is a hyaluronic acid dermal filler (24mg/ml HA + 0.3% lidocaine) clinically proven to correct moderate-to-severe nasolabial folds, marionette lines, and lip augmentation. Utilizing VYCROSS™ technology, it ensures natural-looking volume with 93% patient satisfaction. Results appear immediately, last up to 12 months, and integrate smoothly with facial tissues for minimal downtime.
Juvederm Ultra 2 (2 X 0.55ml)
Juvederm Ultra 2 is an FDA-approved hyaluronic acid filler (24 mg/ml HA + 0.3% lidocaine) specifically engineered for correcting moderate nasolabial folds, perioral lines, and lip augmentation. Clinical trials demonstrate 92% patient satisfaction at 4-week follow-up, with 68% reduction in injection discomfort versus non-anesthetic fillers. Utilizing VYCROSS™ technology, it provides 9-12 month duration through optimized cross-linking density (20% high/80% low molecular weight HA chains) while maintaining 94% natural tissue mobility post-treatment.
Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More
Reviews
Clear filtersThere are no reviews yet.